マイクロバイオーム診断市場、シェア、規模、動向、産業分析レポート：サンプル別、製品別、技術別、用途別、エンドユーザー別、地域別、セグメント予測、2024年～2032年

Polaris Market Research社の最新調査によると、マイクロバイオーム診断の世界市場規模は2032年までに4億8,375万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

個別化医療へのニーズの高まり、疾病発生率の増加、マイクロバイオーム研究のための学界とマイクロバイオーム産業界の協力的な取り組みが、マイクロバイオームベースの診断薬市場を後押ししています。マイクロバイオーム診断市場は、新興国の拡大と、新規マイクロバイオーム技術の開発に関する業界プレイヤーの協力の高まりにより、収益性の高い成長が見込まれます。

マイクロバイオームの商業化は、さまざまな規制政策やガイドラインの影響を受ける多面的なプロセスです。これらの規制は、マイクロバイオームを利用した製品やサービスの安全性と有効性を保証するために設けられています。しかし、これらの規制はマイクロバイオームベースの診断薬市場の商業化と成長にとって大きな障害となることもあります。規制要件は厳格な試験、文書化、承認プロセスを要求することが多く、マイクロバイオームベースの製品を市場に投入しようとする企業にとっては時間とコストがかかります。

さらに、マイクロバイオーム科学は進化し続けているため、規制の枠組みがまだ開発中であったり、変更される可能性があり、商品化プロセスをさらに複雑にしています。このような課題にもかかわらず、消費者の安全を確保し、市場におけるマイクロバイオームベースの製品やサービスの信頼性を維持するためには、規制基準の遵守が不可欠です。

急速に拡大するマイクロバイオーム研究の分野では、数多くの小規模で革新的な企業が、主要な利害関係者に高い成長機会をもたらしています。利害関係者の間では、糖尿病、肝疾患、肥満、代謝性疾患など様々な疾患の診断キットやバイオマーカー標的の特定を中心に、マイクロバイオーム研究のための企業買収への関心が高まっています。市場開拓のリーダー企業は、製品パイプラインを強化するために戦略的提携やパートナーシップを重視し、組織的な研究開発戦略を採用しています。過去2年間、大手企業を巻き込んだ共同研究や提携が顕著に増加しているが、これはヘルスケアやそれ以外におけるマイクロバイオーム研究の重要性と可能性の高まりを反映しています。

マイクロバイオーム診断市場レポートハイライト

マイクロバイオームサンプルの正確かつ精密な分析を可能にすることで、マイクロバイオーム診断において重要な役割を果たす機器セグメントが、2023年の市場を独占しました。

製薬・バイオテクノロジー企業は、革新的な治療法、個別化医療、高度なプロバイオティクスの開発にマイクロバイオームデータを活用することを主な目標としているため、2023年の市場をリードし、今後も優位性を維持すると予測されます。

北米は世界のマイクロバイオーム診断市場において大きな収益シェアを占めており、これは米国とカナダにおける研究開発努力の高まりに大きく後押しされ、大幅な成長を遂げていることによる。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のマイクロバイオーム診断市場の洞察

• マイクロバイオーム診断-業界スナップショット
• マイクロバイオーム診断市場力学
  • 促進要因と機会
    • 個別化医療への移行
    • 学術機関とマイクロバイオーム研究所の提携の増加により、製品の需要が促進されると予測されています。
  • 抑制要因と課題
    • エンドユーザーの資金調達問題が市場の成長を妨げる可能性が高い
• PESTLE分析
• マイクロバイオーム診断業界の動向
• COVID-19の影響分析

第5章 サンプル別の世界市場

• 主な調査結果
• イントロダクション
• 肌
• 糞便
• 唾液
• その他

第6章 製品別の世界市場

• 主な調査結果
• イントロダクション
• 機器
• 試薬とキット

第7章 技術別の世界市場

• 主な調査結果
• イントロダクション
• メタトランスクリプトミクス
• ショットガンメタゲノミクス
• 16s rRNAシーケンシング

第8章 用途別の世界市場

• 主な調査結果
• イントロダクション
• 研究用途
• 病気診断用途

第9章 エンドユーザー別の世界市場

• 主な調査結果
• イントロダクション
• 学術研究機関
• 病院
• 製薬・バイオテクノロジー企業

第10章 地域別の世界市場

• 主な調査結果
• イントロダクション
  • マイクロバイオーム診断市場の評価、地域別、2019-2032年
• マイクロバイオーム診断市場-北米
  • 北米：マイクロバイオーム診断市場、サンプル別、2019年～2032年
  • 北米：マイクロバイオーム診断市場、用途別、2019年～2032年
  • 北米：マイクロバイオーム診断市場、製品別、2019年～2032年
  • 北米：マイクロバイオーム診断市場、技術別、2019年～2032年
  • 北米：マイクロバイオーム診断市場、エンドユーザー別、2019年～2032年
  • マイクロバイオーム診断市場-米国
  • マイクロバイオーム診断市場- カナダ
• マイクロバイオーム診断市場- 欧州
  • 欧州：マイクロバイオーム診断市場、サンプル別、2019-2032年
  • 欧州：マイクロバイオーム診断市場、用途別、2019-2032年
  • 欧州：マイクロバイオーム診断市場、製品別、2019年～2032年
  • 欧州：マイクロバイオーム診断市場、技術別、2019-2032年
  • 欧州：マイクロバイオーム診断市場、エンドユーザー別、2019年～2032年
  • マイクロバイオーム診断市場- 英国
  • マイクロバイオーム診断市場- フランス
  • マイクロバイオーム診断市場- ドイツ
  • マイクロバイオーム診断市場- イタリア
  • マイクロバイオーム診断市場- スペイン
  • マイクロバイオーム診断市場- オランダ
  • マイクロバイオーム診断市場- ロシア
• マイクロバイオーム診断市場- アジア太平洋地域
  • アジア太平洋地域：マイクロバイオーム診断市場、サンプル別、2019年～2032年
  • アジア太平洋地域：マイクロバイオーム診断市場、用途別、2019年～2032年
  • アジア太平洋地域：マイクロバイオーム診断市場、製品別、2019年～2032年
  • アジア太平洋地域：マイクロバイオーム診断市場、技術別、2019年～2032年
  • アジア太平洋地域：マイクロバイオーム診断市場、エンドユーザー別、2019年～2032年
  • マイクロバイオーム診断市場- 中国
  • マイクロバイオーム診断市場- インド
  • マイクロバイオーム診断市場- 日本
  • マイクロバイオーム診断市場- マレーシア
  • マイクロバイオーム診断市場- インドネシア
  • マイクロバイオーム診断市場- 韓国
• マイクロバイオーム診断市場-中東およびアフリカ
  • 中東およびアフリカ：マイクロバイオーム診断市場、サンプル別、2019-2032年
  • 中東およびアフリカ：マイクロバイオーム診断市場、用途別、2019-2032年
  • 中東およびアフリカ：マイクロバイオーム診断市場、製品別、2019-2032年
  • 中東およびアフリカ：マイクロバイオーム診断市場、技術別、2019-2032年
  • 中東およびアフリカ：マイクロバイオーム診断市場、エンドユーザー別、2019-2032年
  • マイクロバイオーム診断市場- サウジアラビア
  • マイクロバイオーム診断市場-UAE
  • マイクロバイオーム診断市場- イスラエル
  • マイクロバイオーム診断市場- 南アフリカ
• マイクロバイオーム診断市場-ラテンアメリカ
  • ラテンアメリカ：マイクロバイオーム診断市場、サンプル別、2019年～2032年
  • ラテンアメリカ：マイクロバイオーム診断市場、用途別、2019-2032年
  • ラテンアメリカ：マイクロバイオーム診断市場、製品別、2019-2032年
  • ラテンアメリカ：マイクロバイオーム診断市場、技術別、2019年～2032年
  • ラテンアメリカ：マイクロバイオーム診断市場、エンドユーザー別、2019年～2032年
  • マイクロバイオーム診断市場- メキシコ
  • マイクロバイオーム診断市場- ブラジル
  • マイクロバイオーム診断市場- アルゼンチン

第11章 競合情勢

• 拡大と買収の分析
  • 拡大
  • 買収
• パートナーシップ/コラボレーション/契約/公開

第12章 企業プロファイル

• DNA Genotek
• Genetic Analysis AS
• Microba
• 4D Pharma PLC
• AOBiome Therapeutics
• Atlas Biomed
• BioGaia
• BIOHM Health
• Bione Ventures Private Limited
• DayTwo
• Enterome
• Evvy
• Ferring Pharmaceuticals
• Finch Therapeutics Group
• Flightpath Biosciences, Inc

List of Tables

• Table 1 Global Microbiome Diagnostics Market, by Sample, by Region, 2019-2032 (USD Million)
• Table 2 Global Microbiome Diagnostics Market, by Product, by Region, 2019-2032 (USD Million)
• Table 3 Global Microbiome Diagnostics Market, by Technology, by Region, 2019-2032 (USD Million)
• Table 4 Global Microbiome Diagnostics Market, by End-User, by Region, 2019-2032 (USD Million)
• Table 5 Global Microbiome Diagnostics Market, by Application, by Region, 2019-2032 (USD Million)
• Table 6 North America: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
• Table 7 North America: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
• Table 8 North America: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
• Table 9 North America: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
• Table 10 North America: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
• Table 11 U.S.: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
• Table 12 U.S.: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
• Table 13 U.S.: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
• Table 14 U.S.: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
• Table 15 U.S.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
• Table 16 Canada: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
• Table 17 Canada: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
• Table 18 Canada: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
• Table 19 Canada: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
• Table 20 Canada: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
• Table 21 Europe: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
• Table 22 Europe: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
• Table 23 Europe: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
• Table 24 Europe: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
• Table 25 Europe: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
• Table 26 Germany: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
• Table 27 Germany: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
• Table 28 Germany: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
• Table 29 Germany: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
• Table 30 Germany: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
• Table 31 France: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
• Table 32 France: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
• Table 33 France: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
• Table 34 France: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
• Table 35 France: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
• Table 36 UK: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
• Table 37 UK: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
• Table 38 UK: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
• Table 39 UK: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
• Table 40 UK: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
• Table 41 Italy: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
• Table 42 Italy: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
• Table 43 Italy: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
• Table 44 Italy: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
• Table 45 Italy: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
• Table 46 Netherlands: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
• Table 47 Netherlands: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
• Table 48 Netherlands: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
• Table 49 Netherlands: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
• Table 50 Netherlands: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
• Table 51 Spain: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
• Table 52 Spain: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
• Table 53 Spain: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
• Table 54 Spain: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
• Table 55 Spain: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
• Table 56 Russia: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
• Table 57 Russia: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
• Table 58 Russia: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
• Table 59 Russia: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
• Table 60 Russia: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
• Table 61 Asia Pacific: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
• Table 62 Asia Pacific: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
• Table 63 Asia Pacific: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
• Table 64 Asia Pacific: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
• Table 65 Asia Pacific: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
• Table 66 China: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
• Table 67 China: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
• Table 68 China: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
• Table 69 China: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
• Table 70 China: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
• Table 71 Japan: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
• Table 72 Japan: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
• Table 73 Japan: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
• Table 74 Japan: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
• Table 75 Japan: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
• Table 76 India: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
• Table 77 India: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
• Table 78 India: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
• Table 79 India: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
• Table 80 India: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
• Table 81 Indonesia: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
• Table 82 Indonesia: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
• Table 83 Indonesia: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
• Table 84 Indonesia: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
• Table 85 Indonesia: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
• Table 86 Malaysia: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
• Table 87 Malaysia: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
• Table 88 Malaysia: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
• Table 89 Malaysia: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
• Table 90 Malaysia: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
• Table 91 South Korea: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
• Table 92 South Korea: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
• Table 93 South Korea: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
• Table 94 South Korea: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
• Table 95 South Korea: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
• Table 96 Latin America: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
• Table 97 Latin America: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
• Table 98 Latin America: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
• Table 99 Latin America: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
• Table 100 Latin America: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
• Table 101 Brazil: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
• Table 102 Brazil: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
• Table 103 Brazil: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
• Table 104 Brazil: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
• Table 105 Brazil: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
• Table 106 Mexico: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
• Table 107 Mexico: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
• Table 108 Mexico: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
• Table 109 Mexico: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
• Table 110 Mexico: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
• Table 111 Argentina: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
• Table 112 Argentina: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
• Table 113 Argentina: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
• Table 114 Argentina: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
• Table 115 Argentina: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
• Table 116 Middle East & Africa: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
• Table 117 Middle East & Africa: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
• Table 118 Middle East & Africa: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
• Table 119 Middle East & Africa: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
• Table 120 Middle East & Africa: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
• Table 121 UAE: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
• Table 122 UAE: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
• Table 123 UAE: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
• Table 124 UAE: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
• Table 125 UAE: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
• Table 126 Saudi Arabia: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
• Table 127 Saudi Arabia: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
• Table 128 Saudi Arabia: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
• Table 129 Saudi Arabia: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
• Table 130 Saudi Arabia: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
• Table 131 South Africa: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
• Table 132 South Africa: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
• Table 133 South Africa: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
• Table 134 South Africa: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
• Table 135 South Africa: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
• Table 136 Israel: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
• Table 137 Israel: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
• Table 138 Israel: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
• Table 139 Israel: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
• Table 140 Israel: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)

List of Figures

• Figure 1. Global Microbiome Diagnostics Market, 2019-2032 (USD Million)
• Figure 2. Integrated Ecosystem
• Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
• Figure 4. Market by Geography
• Figure 5. Porter's Five Forces
• Figure 6. Market by Sample
• Figure 7. Global Microbiome Diagnostics Market, by Sample, 2021 & 2030 (USD Million)
• Figure 8. Market by Product
• Figure 9. Global Microbiome Diagnostics Market, by Product, 2021 & 2030 (USD Million)
• Figure 10. Market by Technology
• Figure 11. Global Microbiome Diagnostics Market, by Technology, 2021 & 2030 (USD Million)
• Figure 12. Market by End-User
• Figure 13. Global Microbiome Diagnostics Market, by End-User, 2021 & 2030 (USD Million)
• Figure 14. Market by Application
• Figure 15. Global Microbiome Diagnostics Market, by Application, 2021 & 2030 (USD Million)

The global microbiome diagnostics market size is expected to reach USD 483.75 million by 2032, according to a new study by Polaris Market Research. The report "Microbiome Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Sample (Skin, Fecal, Saliva); By Product; By Technology; By Application; By End-User; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising need for personalized medicine, increased illness incidence, and cooperative efforts between academia and the microbiome industry for microbiome research are pushing the market for microbiome-based diagnostics. The microbiome diagnostics market is expected to see profitable growth prospects due to the expansion of emerging nations and the growing cooperation of industry players on the development of novel microbiome technologies.

The commercialization of microbiomes is a multifaceted process influenced by a variety of regulatory policies and guidelines. These regulations are put in place to guarantee the safety and effectiveness of microbiome-based products and services. Still, they can also pose significant hurdles to commercialization and growth in the microbiome-based diagnostics market. Regulatory requirements often demand rigorous testing, documentation, and approval processes, which can be time-consuming and costly for companies seeking to bring microbiome-based products to market.

Additionally, the evolving nature of microbiome science means that regulatory frameworks may still be in development or subject to change, further complicating the commercialization process. Despite these challenges, adherence to regulatory standards is crucial for ensuring consumer safety and maintaining the credibility of microbiome-based products and services in the market.

In the rapidly expanding field of microbiome research, numerous small, innovative companies are creating high-growth opportunities for key stakeholders. There is a growing interest among stakeholders to acquire companies for microbiome research, with a focus on identifying diagnostic kits and biomarker targets for various conditions such as diabetes, liver disorders, obesity, and metabolic disorders. Market leaders are emphasizing strategic collaborations and partnerships to strengthen their product pipelines, employing organized research and development strategies. Over the past two years, there has been a noticeable increase in collaborations and partnerships involving major companies, reflecting the growing importance and potential of microbiome research in healthcare and beyond.

Microbiome Diagnostics Market Report Highlights

The instrument segment dominated the market in 2023, driven by its critical role in microbiome diagnostics by enabling the accurate and precise analysis of microbiome samples.

The pharmaceutical & biotechnology companies segment led the market in 2023 and is expected to maintain its dominance due to their primary goal being to utilize microbiome data to create innovative therapies, personalized medicine, and advanced probiotics.

North America holds a significant revenue share in the global Microbiome Diagnostics market, driven by undergoing substantial growth, largely fueled by heightened research and development endeavors in the United States and Canada.

The global key market players include DNA Genotek, Genetic Analysis AS, Microba, 4D Pharma PLC, AOBiome Therapeutics, Atlas Biomed, BioGaia, BIOHM Health, Bione Ventures Private Limited, DayTwo, Enterome, and Evvy,

Polaris Market Research has segmented the Microbiome Diagnostics market report based on sample, product, technology, application, end-user, and region:

Microbiome Diagnostics, Sample Outlook (Revenue - USD Million, 2019 - 2032)

• Skin
• Fecal
• Saliva
• Others

Microbiome Diagnostics, Product Outlook (Revenue - USD Million, 2019 - 2032)

• Instruments
• Reagents & Kits

Microbiome Diagnostics, Technology Outlook (Revenue - USD Million, 2019 - 2032)

• Metatranscriptomics
• Shot Gun Metagenomics
• 16s rRNA Sequencing

Microbiome Diagnostics, Application Outlook (Revenue - USD Million, 2019 - 2032)

• Research Application
• Disease Diagnostics Application
• Metabolic Diseases
• Gastrointestinal Disorders
• Others

Microbiome Diagnostics, End-User Outlook (Revenue - USD Million, 2019 - 2032)

• Academic & Research Institutes
• Hospitals
• Pharmaceutical & Biotechnology Companies

Microbiome Diagnostics, Regional Outlook (Revenue - USD Million, 2019 - 2032)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Netherlands
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Malaysia
• Australia
• Rest of Asia Pacific
• Latin America
• Argentina
• Brazil
• Mexico
• Rest of Latin America
• Middle East & Africa
• UAE
• Saudi Arabia
• Israel
• South Africa
• Rest of Middle East & Africa

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global Microbiome Diagnostics Market Insights

• 4.1. Microbiome Diagnostics - Industry Snapshot
• 4.2. Microbiome Diagnostics Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Shift Towards Personalized Medicine
    • 4.2.1.2. A rising number of partnerships between academic and microbiome institutes is projected to spur product demand
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. Financing problems from end-users are likely to impede the market growth
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTLE Analysis
• 4.5. Microbiome Diagnostics Industry Trends
• 4.6. COVID-19 Impact Analysis

5. Global Microbiome Diagnostics Market, by Sample

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
• 5.3. Skin
  • 5.3.1. Global Microbiome Diagnostics Market, by Skin, by Region, 2019-2032 (USD Million)
• 5.4. Fecal
  • 5.4.1. Global Microbiome Diagnostics Market, by Fecal, by Region, 2019-2032 (USD Million)
• 5.5. Saliva
  • 5.5.1. Global Microbiome Diagnostics Market, by Saliva, by Region, 2019-2032 (USD Million)
• 5.6. Others
  • 5.6.1. Global Microbiome Diagnostics Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Microbiome Diagnostics Market, by Product

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
• 6.3. Instruments
  • 6.3.1. Global Microbiome Diagnostics Market, by Instruments, by Region, 2019-2032 (USD Million)
• 6.4. Reagents & Kits
  • 6.4.1. Global Microbiome Diagnostics Market, by Reagents & Kits, by Region, 2019-2032 (USD Million)

7. Global Microbiome Diagnostics Market, by Technology

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Global Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
• 7.3. Metatranscriptomics
  • 7.3.1. Global Microbiome Diagnostics Market, by Metatranscriptomics, by Region, 2019-2032 (USD Million)
• 7.4. Shot Gun Metagenomics
  • 7.4.1. Global Microbiome Diagnostics Market, by Shot Gun Metagenomics, by Region, 2019-2032 (USD Million)
• 7.4. 16s rRNA Sequencing
  • 7.4.1. Global Microbiome Diagnostics Market, by 16s rRNA Sequencing, by Region, 2019-2032 (USD Million)

8. Global Microbiome Diagnostics Market, by Application

• 8.1. Key Findings
• 8.2. Introduction
  • 8.2.1. Global Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
• 8.3. Research Application
  • 8.3.1. Global Microbiome Diagnostics Market, by Research Application, by Region, 2019-2032 (USD Million)
• 8.4. Disease Diagnostics Application
  • 8.4.1. Global Microbiome Diagnostics Market, by Disease Diagnostics Application, by Region, 2019-2032 (USD Million)
  • 8.4.2. Metabolic Diseases
    • 8.4.2.1. Global Microbiome Diagnostics Market, by Metabolic Diseases, by Region, 2019-2032 (USD Million)
  • 8.4.3. Gastrointestinal Disorders
    • 8.4.3.1. Global Microbiome Diagnostics Market, by Gastrointestinal Disorders, by Region, 2019-2032 (USD Million)
  • 8.4.4. Others
    • 8.4.4.1. Global Microbiome Diagnostics Market, by Others, by Region, 2019-2032 (USD Million)

9. Global Microbiome Diagnostics Market, by End-User

• 9.1. Key Findings
• 9.2. Introduction
  • 9.2.1. Global Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
• 9.3. Academic & Research Institutes
  • 9.3.1. Global Microbiome Diagnostics Market, by Academic & Research Institutes, by Region, 2019-2032 (USD Million)
• 9.4. Hospitals
  • 9.4.1. Global Microbiome Diagnostics Market, by Hospitals, by Region, 2019-2032 (USD Million)
• 9.5. Pharmaceutical & Biotechnology Companies
  • 9.5.1. Global Microbiome Diagnostics Market, by Pharmaceutical & Biotechnology Companies, by Region, 2019-2032 (USD Million)

10. Global Microbiome Diagnostics Market, by Geography

• 10.1. Key findings
• 10.2. Introduction
  • 10.2.1. Microbiome Diagnostics Market Assessment, By Geography, 2019-2032 (USD Million)
• 10.3. Microbiome Diagnostics Market - North America
  • 10.3.1. North America: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
  • 10.3.2. North America: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
  • 10.3.3. North America: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
  • 10.3.4. North America: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • 10.3.5. North America: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • 10.3.6. Microbiome Diagnostics Market - U.S.
    • 10.3.6.1. U.S.: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
    • 10.3.6.2. U.S.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
    • 10.3.6.3. U.S.: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
    • 10.3.6.4. U.S.: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 10.3.6.5. U.S.: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • 10.3.7. Microbiome Diagnostics Market - Canada
    • 10.3.7.1. Canada: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
    • 10.3.7.2. Canada.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
    • 10.3.7.3. Canada: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
    • 10.3.7.4. Canada: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 10.3.7.5. Canada: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
• 10.4. Microbiome Diagnostics Market - Europe
  • 10.4.1. Europe: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
  • 10.4.2. Europe.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
  • 10.4.3. Europe: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
  • 10.4.4. Europe: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • 10.4.5. Europe: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • 10.4.6. Microbiome Diagnostics Market - UK
    • 10.4.6.1. UK: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
    • 10.4.6.2. UK.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
    • 10.4.6.3. UK: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
    • 10.4.6.4. UK: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 10.4.6.5. UK: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • 10.4.7. Microbiome Diagnostics Market - France
    • 10.4.7.1. France: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
    • 10.4.7.2. France.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
    • 10.4.7.3. France: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
    • 10.4.7.4. France: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 10.4.7.5. France: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • 10.4.8. Microbiome Diagnostics Market - Germany
    • 10.4.8.1. Germany: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
    • 10.4.8.2. Germany.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
    • 10.4.8.3. Germany: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
    • 10.4.8.4. Germany: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 10.4.8.5. Germany: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • 10.4.9. Microbiome Diagnostics Market - Italy
    • 10.4.9.1. Italy: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
    • 10.4.9.2. Italy.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
    • 10.4.9.3. Italy: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
    • 10.4.9.4. Italy: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 10.4.9.5. Italy: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • 10.4.10. Microbiome Diagnostics Market - Spain
    • 10.4.10.1. Spain: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
    • 10.4.10.2. Spain.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
    • 10.4.10.3. Spain: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
    • 10.4.10.4. Spain: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 10.4.10.5. Spain: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • 10.4.11. Microbiome Diagnostics Market - Netherlands
    • 10.4.11.1. Netherlands: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
    • 10.4.11.2. Netherlands.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
    • 10.4.11.3. Netherlands: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
    • 10.4.11.4. Netherlands: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 10.4.11.5. Netherlands: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • 10.4.12. Microbiome Diagnostics Market - Russia
    • 10.4.12.1. Russia: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
    • 10.4.12.2. Russia.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
    • 10.4.12.3. Russia: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
    • 10.4.12.4. Russia: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 10.4.12.5. Russia: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
• 10.5. Microbiome Diagnostics Market - Asia Pacific
  • 10.5.1. Asia Pacific: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
  • 10.5.2. Asia Pacific.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
  • 10.5.3. Asia Pacific: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
  • 10.5.4. Asia Pacific: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • 10.5.5. Asia Pacific: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • 10.5.6. Microbiome Diagnostics Market - China
    • 10.5.6.1. China: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
    • 10.5.6.2. China.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
    • 10.5.6.3. China: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
    • 10.5.6.4. China: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 10.5.6.5. China: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • 10.5.7. Microbiome Diagnostics Market - India
    • 10.5.7.1. India: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
    • 10.5.7.2. India.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
    • 10.5.7.3. India: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
    • 10.5.7.4. India: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 10.5.7.5. India: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • 10.5.8. Microbiome Diagnostics Market - Japan
    • 10.5.8.1. Japan: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
    • 10.5.8.2. Japan.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
    • 10.5.8.3. Japan: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
    • 10.5.8.4. Japan: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 10.5.8.5. Japan: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • 10.5.9. Microbiome Diagnostics Market - Malaysia
    • 10.5.9.1. Malaysia: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
    • 10.5.9.2. Malaysia.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
    • 10.5.9.3. Malaysia: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
    • 10.5.9.4. Malaysia: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 10.5.9.5. Malaysia: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • 10.5.10. Microbiome Diagnostics Market - Indonesia
    • 10.5.10.1. Indonesia: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
    • 10.5.10.2. Indonesia.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
    • 10.5.10.3. Indonesia: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
    • 10.5.10.4. Indonesia: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 10.5.10.5. Indonesia: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • 10.5.11. Microbiome Diagnostics Market - South Korea
    • 10.5.11.1. South Korea: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
    • 10.5.11.2. South Korea.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
    • 10.5.11.3. South Korea: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
    • 10.5.11.4. South Korea: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 10.5.11.5. South Korea: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
• 10.6. Microbiome Diagnostics Market - Middle East & Africa
  • 10.6.1. Middle East & Africa: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
  • 10.6.2. Middle East & Africa: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
  • 10.6.3. Middle East & Africa: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
  • 10.6.4. Middle East & Africa: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • 10.6.5. Middle East & Africa: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • 10.6.6. Microbiome Diagnostics Market - Saudi Arabia
    • 10.6.6.1. Saudi Arabia: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
    • 10.6.6.2. Saudi Arabia.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
    • 10.6.6.3. Saudi Arabia: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
    • 10.6.6.4. Saudi Arabia: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 10.6.6.5. Saudi Arabia: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • 10.6.7. Microbiome Diagnostics Market - UAE
    • 10.6.7.1. UAE: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
    • 10.6.7.2. UAE.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
    • 10.6.7.3. UAE: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
    • 10.6.7.4. UAE: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 10.6.7.5. UAE: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • 10.6.8. Microbiome Diagnostics Market - Israel
    • 10.6.8.1. Israel: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
    • 10.6.8.2. Israel.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
    • 10.6.8.3. Israel: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
    • 10.6.8.4. Israel: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 10.6.8.5. Israel: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • 10.6.9. Microbiome Diagnostics Market - South Africa
    • 10.6.9.1. South Africa: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
    • 10.6.9.2. South Africa.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
    • 10.6.9.3. South Africa: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
    • 10.6.9.4. South Africa: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 10.6.9.5. South Africa: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
• 10.7. Microbiome Diagnostics Market - Latin America
  • 10.7.1. Latin America: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
  • 10.7.2. Latin America.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
  • 10.7.3. Latin America: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
  • 10.7.4. Latin America: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • 10.7.5. Latin America: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • 10.7.6. Microbiome Diagnostics Market - Mexico
    • 10.7.6.1. Mexico: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
    • 10.7.6.2. Mexico.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
    • 10.7.6.3. Mexico: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
    • 10.7.6.4. Mexico: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 10.7.6.5. Mexico: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • 10.7.7. Microbiome Diagnostics Market - Brazil
    • 10.7.7.1. Brazil: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
    • 10.7.7.2. Brazil.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
    • 10.7.7.3. Brazil: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
    • 10.7.7.4. Brazil: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 10.7.7.5. Brazil: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)
  • 10.7.8. Microbiome Diagnostics Market - Argentina
    • 10.7.8.1. Argentina: Microbiome Diagnostics Market, by Sample, 2019-2032 (USD Million)
    • 10.7.8.2. Argentina.: Microbiome Diagnostics Market, by Application, 2019-2032 (USD Million)
    • 10.7.8.3. Argentina: Microbiome Diagnostics Market, by Product, 2019-2032 (USD Million)
    • 10.7.8.4. Argentina: Microbiome Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 10.7.8.5. Argentina: Microbiome Diagnostics Market, by End-User, 2019-2032 (USD Million)

11. Competitive Landscape

• 11.1. Expansion and Acquisition Analysis
  • 11.1.1. Expansion
  • 11.1.2. Acquisitions
• 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

• 12.1. DNA Genotek
  • 12.1.1. Company Overview
  • 12.1.2. Financial Performance
  • 12.1.3. Product Benchmarking
  • 12.1.4. Recent Development
• 12.2. Genetic Analysis AS
  • 12.2.1. Company Overview
  • 12.2.2. Financial Performance
  • 12.2.3. Product Benchmarking
  • 12.2.4. Recent Development
• 12.3. Microba
  • 12.3.1. Company Overview
  • 12.3.2. Financial Performance
  • 12.3.3. Product Benchmarking
  • 12.3.4. Recent Development
• 12.4. 4D Pharma PLC
  • 12.4.1. Company Overview
  • 12.4.2. Financial Performance
  • 12.4.3. Product Benchmarking
  • 12.4.4. Recent Development
• 12.5. AOBiome Therapeutics
  • 12.5.1. Company Overview
  • 12.5.2. Financial Performance
  • 12.5.3. Product Benchmarking
  • 12.5.4. Recent Development
• 12.6. Atlas Biomed
  • 12.6.1. Company Overview
  • 12.6.2. Financial Performance
  • 12.6.3. Product Benchmarking
  • 12.6.4. Recent Development
• 12.7. BioGaia
  • 12.7.1. Company Overview
  • 12.7.2. Financial Performance
  • 12.7.3. Product Benchmarking
  • 12.7.4. Recent Development
• 12.8. BIOHM Health
  • 12.8.1. Company Overview
  • 12.8.2. Financial Performance
  • 12.8.3. Product Benchmarking
  • 12.8.4. Recent Development
• 12.9. Bione Ventures Private Limited
  • 12.9.1. Company Overview
  • 12.9.2. Financial Performance
  • 12.9.3. Product Benchmarking
  • 12.9.4. Recent Development
• 12.10. DayTwo
  • 12.10.1. Company Overview
  • 12.10.2. Financial Performance
  • 12.10.3. Product Benchmarking
  • 12.10.4. Recent Development
• 12.11. Enterome
  • 12.11.1. Company Overview
  • 12.11.2. Financial Performance
  • 12.11.3. Product Benchmarking
  • 12.11.4. Recent Development
• 12.12. Evvy
  • 12.12.1. Company Overview
  • 12.12.2. Financial Performance
  • 12.12.3. Product Benchmarking
  • 12.12.4. Recent Development
• 12.13. Ferring Pharmaceuticals
  • 12.13.1. Company Overview
  • 12.13.2. Financial Performance
  • 12.13.3. Product Benchmarking
  • 12.13.4. Recent Development
• 12.14. Finch Therapeutics Group
  • 12.14.1. Company Overview
  • 12.14.2. Financial Performance
  • 12.14.3. Product Benchmarking
  • 12.14.4. Recent Development
• 12.15. Flightpath Biosciences, Inc
  • 12.15.1. Company Overview
  • 12.15.2. Financial Performance
  • 12.15.3. Product Benchmarking
  • 12.15.4. Recent Development